Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Nitazoxanide on Virologic Responses in Chronic HCV Infected Patients With Genotype 4: A Placebo-controlled Randomized Trial

NCT01197157 is registered in ClinicalTrials.gov with National Liver Institute, Egypt as lead sponsor.

NCT NCT01197157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01197157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Nitazoxanide on Virologic Responses in Chronic HCV Infected Patients With Genotype 4: A Placebo-controlled Randomized Trial
Lead sponsor
National Liver Institute, Egypt
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2010
Completion date
April 30, 2014
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c